@paulsweeney The interesting thing is that the economic incentives *do* exist.
Even in the U.S., the government is the primary purchaser of medicine and medical services; outside the U.S., it is often almost the *sole* purchaser. So if investing millions in trials for less-expensive remedies means saving billions in taxpayer dollars, the math is pretty simple.
And it does happen: there are huge trials for practices like active surveillance, different surgical interventions, ADT holidays, etc, that don't have any commercial potential. STAMPEDE is an excellent example of a long-running, multi-faceted trial that has had a big impact on us as prostate-cancer patients.
So if a natural remedy hasn't had a major trial, it's not just because it has no commercial potential for pharma companies; it's because data from early, small-scale academic studies hasn't been sufficient, consistent, or persuasive enough to take it to the next level.
@northoftheborder good point, well made.